The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. TOWA Pharmaceutical Co's current ratio for the quarter that ended in Mar. 2026 was 2.76.
TOWA Pharmaceutical Co has a current ratio of 2.76. It generally indicates good short-term financial strength.
The historical rank and industry rank for TOWA Pharmaceutical Co's Current Ratio or its related term are showing as below:
TWAPF'
s Current Ratio Range Over the Past 10 Years
Min: 1.45 Med: 2.64 Max: 2.91
Current: 2.76
During the past 13 years, TOWA Pharmaceutical Co's highest Current Ratio was 2.91. The lowest was 1.45. And the median was 2.64.
TWAPF's Current Ratio is ranked better than 64.12% of 995
companies
in the Drug Manufacturers industry
Industry Median: 2
vs TWAPF: 2.76
TOWA Pharmaceutical Co (OTCPK:TWAPF) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
TOWA Pharmaceutical Co Current Ratio Related Terms
TOWA Pharmaceutical Co Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, TOWA Pharmaceutical Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TOWA Pharmaceutical Co Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TOWA Pharmaceutical Co's Current Ratio distribution charts can be found below:
* The bar in red indicates where TOWA Pharmaceutical Co's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TOWA Pharmaceutical Co (TWAPF) has a Current Ratio of 2.76 as of Mar. 2026. This is near median its historical median of 2.64. Over the past decade, TOWA Pharmaceutical Co's Current Ratio has ranged from 1.45 to 2.91. According to the industry distribution chart, TOWA Pharmaceutical Co ranks #357 out of 995 companies in the Drug Manufacturers industry, placing it in the top 35.9%.
Is TOWA Pharmaceutical Co's Current Ratio too high?
TOWA Pharmaceutical Co's current Current Ratio of 2.76 is near median its 10-year median of 2.64. Over the past 10 years, this metric has ranged from a low of 1.45 to a high of 2.91. The Drug Manufacturers industry median Current Ratio is 2.00. TOWA Pharmaceutical Co's value of 2.76 is 38% above this industry median. Based on the distribution chart, TOWA Pharmaceutical Co ranks #357 out of 995 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, TOWA Pharmaceutical Co has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does TOWA Pharmaceutical Co's Current Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, TOWA Pharmaceutical Co ranks #357 out of 995 companies for Current Ratio. This puts TOWA Pharmaceutical Co in the upper half of its industry. The industry median Current Ratio is 2.00. TOWA Pharmaceutical Co's value of 2.76 is 38% above this benchmark. Historically, TOWA Pharmaceutical Co's own Current Ratio has ranged from 1.45 to 2.91 over the past decade. While the company's 10-year median is 2.64 vs. the industry median of 2.00, TOWA Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 995 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TOWA Pharmaceutical Co's current Current Ratio of 2.76 is 38% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TOWA Pharmaceutical Co's current Current Ratio is 2.76, which is near median its own 10-year median of 2.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TOWA Pharmaceutical Co stock overvalued right now?
TOWA Pharmaceutical Co (TWAPF) has a current Current Ratio of 2.76. The stock's GF Value™ is $15.06, compared to a current price of $16.83 — trading 11.8% above its estimated fair value. The current Current Ratio is 2.76, which is near median its 10-year median of 2.64 and 38% above the Drug Manufacturers industry median of 2.00. TOWA Pharmaceutical Co's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For TOWA Pharmaceutical Co (TWAPF), the current Current Ratio is 2.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TOWA Pharmaceutical Co (TWAPF) Overvalued in 2026?
Based on GuruFocus' analysis, TOWA Pharmaceutical Co stock appears to be overvalued.
The current stock price of $16.83 is trading 11.8% above its estimated GF Value™ of $15.06.
Key valuation signals for TWAPF:
Current Ratio: 2.76 (near median its 10-year median of 2.64)
GF Value™: $15.06 vs. price of $16.83 (11.8% above fair value)
Industry Position: 38% above the Drug Manufacturers median (#357 of 995)
No single metric tells the full story. See the TWAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.
86GF Score
Get the complete analysis for TWAPF
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TWAPF has been successfully added to your 
